XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues    
Total revenues $ 83,247 $ 86,233
Costs of revenue (exclusive of amortization and depreciation)    
Costs to obtain and fulfill contracts capitalized 41,759 44,177
Product development 10,689 8,352
Sales and marketing 6,592 6,957
General and administrative 19,396 14,453
Amortization 5,869 5,500
Depreciation 400 499
Total expenses 84,705 79,938
Operating income (loss) (1,458) 6,295
Other income (expense):    
Other income 1,422 267
Interest expense (4,072) (2,669)
Total other income (expense) (2,650) (2,402)
Income (loss) before taxes (4,108) 3,893
Provision (benefit) for income taxes (1,592) 809
Net income (loss) $ (2,516) $ 3,084
Net income (loss) per common share—basic (in dollars per share) $ (0.17) $ 0.21
Net income (loss) per common share—diluted (in dollars per share) $ (0.17) $ 0.21
Weighted average shares outstanding used in per common share computations:    
Basic (in shares) 14,234 14,136
Diluted (in shares) 14,234 14,136
RCM    
Revenues    
Total revenues $ 53,038 $ 48,631
Costs of revenue (exclusive of amortization and depreciation)    
Costs to obtain and fulfill contracts capitalized 29,597 27,183
EHR    
Revenues    
Total revenues 28,022 35,191
Costs of revenue (exclusive of amortization and depreciation)    
Costs to obtain and fulfill contracts capitalized 11,287 16,348
Patient Engagement    
Revenues    
Total revenues 2,187 2,411
Costs of revenue (exclusive of amortization and depreciation)    
Costs to obtain and fulfill contracts capitalized $ 875 $ 646